Exploring the Policies Applied to Pharmaceutical Care Practice for Type 2 Diabetes over the Last Decade in European Community Pharmacies.

In the last decade (2010-2020), more than half of European countries have improved their health policies within the primary care for type 2 . Community pharmacies have been and could continue to be essential actors in this evolution of fighting the disease by providing a set of pharmacotherapeutic follow-up services for the person with diabetes. These services, designated by the Pharmaceutical Group of the European Union as "" and "", have aimed to optimize adherence to therapy and improve health outcomes.

Online Pharmaceutical Care Provision: Full-Implementation of an eHealth Service Using Design Science Research.

Chronic diseases are pressing health systems to introduce reforms, focused on primary care and multidisciplinary models. Community pharmacists have developed a new role, addressing pharmaceutical care and services. Information systems and technologies (IST) will have an important role in shaping future healthcare provision.